PL2320908T3 - Proleki dolutegrawiru - Google Patents

Proleki dolutegrawiru

Info

Publication number
PL2320908T3
PL2320908T3 PL09800989T PL09800989T PL2320908T3 PL 2320908 T3 PL2320908 T3 PL 2320908T3 PL 09800989 T PL09800989 T PL 09800989T PL 09800989 T PL09800989 T PL 09800989T PL 2320908 T3 PL2320908 T3 PL 2320908T3
Authority
PL
Poland
Prior art keywords
dolutegravir
prodrugs
dolutegravir prodrugs
Prior art date
Application number
PL09800989T
Other languages
English (en)
Inventor
Brian Alvin Johns
Jason Gordon Weatherhead
Yasunori Aoyama
Toshikazu Hakogi
Original Assignee
Viiv Healthcare Co
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viiv Healthcare Co, Shionogi & Co filed Critical Viiv Healthcare Co
Publication of PL2320908T3 publication Critical patent/PL2320908T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL09800989T 2008-07-25 2009-07-23 Proleki dolutegrawiru PL2320908T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8361208P 2008-07-25 2008-07-25
EP09800989.7A EP2320908B9 (en) 2008-07-25 2009-07-23 Dolutegravir Prodrugs
PCT/US2009/051497 WO2010011812A1 (en) 2008-07-25 2009-07-23 Chemical compounds

Publications (1)

Publication Number Publication Date
PL2320908T3 true PL2320908T3 (pl) 2014-06-30

Family

ID=41570593

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09800989T PL2320908T3 (pl) 2008-07-25 2009-07-23 Proleki dolutegrawiru

Country Status (12)

Country Link
US (1) US8217034B2 (pl)
EP (1) EP2320908B9 (pl)
CY (1) CY1114981T1 (pl)
DK (1) DK2320908T3 (pl)
ES (1) ES2448766T3 (pl)
HR (1) HRP20140223T2 (pl)
HU (1) HUE020489T4 (pl)
PL (1) PL2320908T3 (pl)
PT (1) PT2320908E (pl)
SI (1) SI2320908T1 (pl)
SM (1) SMT201400030B (pl)
WO (1) WO2010011812A1 (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG192550A1 (en) 2008-07-25 2013-08-30 Viiv Healthcare Co Chemical compounds
EP2376453B1 (en) 2008-12-11 2019-11-20 VIIV Healthcare Company Intermediates for carbamoylpyridone hiv integrase inhibitors
US8710249B2 (en) 2008-12-11 2014-04-29 Shionogi & Co., Ltd. Maltol ether processes and intermediates
EP2376080B1 (en) 2008-12-11 2017-09-13 Shionogi&Co., Ltd. Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
AU2014277831C1 (en) * 2008-12-11 2022-10-06 Shionogi & Co. Ltd. Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
TWI518084B (zh) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 哌喃酮與吡啶酮衍生物之製造方法
EA032868B1 (ru) 2010-01-27 2019-07-31 Вайв Хелткер Компани Комбинация для лечения вич-инфекции
TWI582097B (zh) 2010-03-23 2017-05-11 Viiv醫療保健公司 製備胺甲醯吡啶酮衍生物及中間體之方法
US9216995B2 (en) 2010-04-12 2015-12-22 Shionogi & Co., Ltd. Pyridone derivative having integrase inhibitory activity
ES2608377T3 (es) 2010-08-05 2017-04-10 Shionogi & Co., Ltd. Procedimiento de preparación de un compuesto que tiene actividad inhibidora de la integrasa del HIV
CN103228653B (zh) * 2010-09-24 2016-03-16 盐野义制药株式会社 被取代的多环性氨基甲酰基吡啶酮衍生物的前药
EP2742051B1 (en) * 2011-09-14 2016-10-12 Mapi Pharma Limited Amorpous form of the dolutegravir sodium salt
MX344879B (es) 2012-12-21 2017-01-11 Gilead Sciences Inc Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico.
US9573965B2 (en) 2013-02-19 2017-02-21 Aurobindo Pharma Ltd Process for the preparation of Dolutegravir
US9951079B2 (en) 2013-06-13 2018-04-24 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
WO2015001572A2 (en) * 2013-07-04 2015-01-08 Hetero Research Foundation Process for the preparation of intermediate of dolutegravir
LT3019503T (lt) 2013-07-12 2017-11-27 Gilead Sciences, Inc. Policikliniai karbamoilpiridono junginiai ir jų panaudojimas živ infekcijų gydymui
NO2865735T3 (pl) 2013-07-12 2018-07-21
WO2015009927A1 (en) * 2013-07-17 2015-01-22 Ratiopharm Gmbh Dolutegravir salts
WO2015110897A2 (en) 2014-01-21 2015-07-30 Laurus Labs Private Limited Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
TWI744723B (zh) 2014-06-20 2021-11-01 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
NO2717902T3 (pl) 2014-06-20 2018-06-23
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
TWI738321B (zh) 2014-12-23 2021-09-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
WO2016102078A1 (en) 2014-12-24 2016-06-30 Ratiopharm Gmbh Solid state forms of dolutegravir sodium
CA2980362C (en) 2015-04-02 2020-02-25 Gilead Sciences, Inc. Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
WO2017223280A2 (en) * 2016-06-23 2017-12-28 Viiv Healthcare Company Compositions and methods for the delivery of therapeutics
CN106360086B (zh) * 2016-09-23 2020-06-30 皖西学院 一种皖西白鹅种鹅专用饲料组合物、制备方法及使用方法
CN108250215B (zh) * 2016-12-28 2022-04-19 华创合成制药股份有限公司 一种新型抗hiv药物及其制备方法和用途
EP3573984A4 (en) * 2017-01-26 2020-07-29 Merck Sharp & Dohme Corp. USEFUL SUBSTITUTE QUINOLIZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS
RU2755710C2 (ru) 2017-06-30 2021-09-20 Вайв Хелткер Компани Комбинация, ее применение и способы лечения с использованием указанной комбинации
CN111386276B (zh) 2017-10-06 2023-06-23 盐野义制药株式会社 制备取代的多环吡啶酮衍生物的立体选择性方法
SI3938047T1 (sl) 2019-03-22 2022-10-28 Gilead Sciences, Inc. Premoščene triciklične karbamoilpiridonske spojine in njihova farmacevtska uporaba
WO2021173522A1 (en) 2020-02-24 2021-09-02 Gilead Sciences, Inc. Tetracyclic compounds for treating hiv infection
KR20230079137A (ko) 2020-09-30 2023-06-05 길리애드 사이언시즈, 인코포레이티드 가교된 트리사이클릭 카르바모일피리돈 화합물 및 이의 용도
EP4249077A4 (en) 2020-11-17 2025-02-12 Shionogi & Co., Ltd NEW ACRIDINIUM SALT AND METHOD FOR THE PRODUCTION THEREOF
PT4196479T (pt) 2021-01-19 2024-01-03 Gilead Sciences Inc Compostos de piridotriazinas substituídos e suas utilizações
JP2024507788A (ja) * 2021-02-16 2024-02-21 メルク・シャープ・アンド・ドーム・エルエルシー Hivインテグラーゼ阻害剤として有用な四環式複素環化合物
WO2023183472A1 (en) * 2022-03-23 2023-09-28 Board Of Regents Of The University Of Nebraska Antiviral prodrugs and use thereof
EP4493708A1 (en) 2022-04-04 2025-01-22 University of the Witwatersrand, Johannesburg Enantioselective methods for preparing chiral amine intermediates
TWI856796B (zh) 2022-04-06 2024-09-21 美商基利科學股份有限公司 橋聯三環胺甲醯基吡啶酮化合物及其用途
WO2025080863A1 (en) 2023-10-11 2025-04-17 Gilead Sciences, Inc. Bridged tricyclic carbamoylpyridone compounds and uses thereof
US20250127801A1 (en) 2023-10-11 2025-04-24 Gilead Sciences, Inc. Bridged tricyclic carbamoylpyridone compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005010413D1 (de) * 2004-04-14 2008-11-27 Zhenhong R Cai Phosphonatanaloga von hiv-integrasehemmerverbindungen
JP5317257B2 (ja) * 2005-02-21 2013-10-16 塩野義製薬株式会社 Hivインテグラーゼ阻害活性を有する2環性カルバモイルピリドン誘導体
US8129385B2 (en) * 2005-04-28 2012-03-06 Shionogi & Co., Ltd. Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness
TW200716632A (en) * 2005-05-16 2007-05-01 Gilead Sciences Inc Integrase inhibitor compounds

Also Published As

Publication number Publication date
HRP20140223T1 (en) 2014-04-11
EP2320908B1 (en) 2013-12-25
HRP20140223T2 (hr) 2014-08-01
CY1114981T1 (el) 2016-12-14
US20110190236A1 (en) 2011-08-04
US8217034B2 (en) 2012-07-10
EP2320908A1 (en) 2011-05-18
EP2320908B9 (en) 2014-06-18
PT2320908E (pt) 2014-03-06
SI2320908T1 (sl) 2014-05-30
EP2320908A4 (en) 2011-10-26
WO2010011812A1 (en) 2010-01-28
DK2320908T3 (en) 2014-03-10
SMT201400030B (it) 2014-05-07
ES2448766T9 (es) 2014-09-05
ES2448766T3 (es) 2014-03-17
HUE020489T4 (hu) 2016-01-28

Similar Documents

Publication Publication Date Title
SI2320908T1 (sl) Predzdravila dolutegravirja
GB0809631D0 (en) Zonesense
EP2118052A4 (en) NEW PRODRUGS
TWI368572B (en) Printing-table arrangement
EP2233305A4 (en) GRAPHIC PRINTER
GB0804525D0 (en) Lamstone
GB2463042B (en) Stabalizer arrangement
GB0810659D0 (en) Permenforce
GB0804158D0 (en) Fencemate
GB0803221D0 (en) Wrist-pull
AU3977P (en) PARV01 Myoporum parvifolium
GB0905127D0 (en) Novel prodrugs
GB0808203D0 (en) Test4time
GB0811486D0 (en) Corcostpres011
GB0802454D0 (en) Thread-erzi
GB0803147D0 (en) Subtider
GB0804157D0 (en) Finooker
GB0801979D0 (en) Thermo-pile
GB0804424D0 (en) Airboat
AU2008213V (en) Scasalute Scaevola aemula
GB0815146D0 (en) Autocall
AU2008295V (en) Canobolas xTriticosecale
GB0814188D0 (en) Magnamo
GB0801969D0 (en) Ladderbar
GB0814148D0 (en) Multihang